Effects of dutasteride with Bacillus Calmette-Guérin therapy on recurrence, progression, metastasis, and survival in non-muscle invasive bladder cancer: a retrospective single-center study

Key Points

• Dutasteride combined with Bacillus Calmette-Guerin therapy reduces recurrence rates significantly in non-muscle invasive bladder cancer.
• The study found a notable impact on disease progression, with a reduction observed in the study population.
• Assessment involved a retrospective single-center analysis, focusing on patient outcomes over the treatment period.
• These findings highlight the potential for improved survival outcomes, emphasizing the need for additional research on therapy combinations.